ICAM1 and metastatic colorectal cancer: In a recent study, the CD133+ CD44+ CD54+ subpopulation of CTCs has a prognostic value in metastatic colorectal cancer and shows a significant survival improvement in patients who did not undergo surgical treatment for metastasis [65].